Trials / Completed
CompletedNCT01394029
Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox
International Sentinel Site Surveillance of Patients With Transfusional Hemosiderosis Treated With Deferasirox in Actual Practice Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
This study will observe patients with transfusional hemosiderosis treated with deferasirox in actual practice setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | deferasirox |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2011-07-14
- Last updated
- 2016-02-02
Locations
10 sites across 4 countries: Egypt, Jordan, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01394029. Inclusion in this directory is not an endorsement.